THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR TO BE TRANSMITTED, DISTRIBUTED TO, OR SENT BY, ANY NATIONAL OR RESIDENT OR CITIZEN OF ANY SUCH COUNTRIES OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION MAY CONTRAVENE LOCAL SECURITIES LAWS OR REGULATIONS.

LONDON, Oct. 20, 2026 (GLOBE NEWSWIRE) —

Pulsar Helium Inc. (AIM: PLSR, TSXV: PLSR, OTCQB: PSRHF) (“Pulsar” or the “Company”), a primary helium company, is pleased to announce that Thomas Abraham-James, Pulsar’s CEO, and Cliff Cain, Pulsar’s President, will host a live “Ask me Anything” session via the Investor Meet Company platform on Tuesday, October 27th, 2026, at 15:30 GMT (10:30 CDT).

The session will provide shareholders and interested parties with the opportunity to engage directly with management, with Thomas and Cliff responding to investor questions in real time.

The webinar is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until Monday, October 26th, 2026, at 09:00 am GMT, or at any time during the live webinar.

Investors can sign up to Investor Meet Company for free to meet Pulsar Helium Inc. via:

https://www.investormeetcompany.com/pulsar-helium-inc-1/register-investor

Investors who already follow Pulsar Helium Inc. on the Investor Meet Company platform will automatically be invited.

On behalf of Pulsar Helium Inc.
“Thomas Abraham-James”
CEO and Director

Further Information:

Pulsar Helium Inc.
connect@pulsarhelium.com
+ 1 (218) 203-5301 (USA/Canada)

+44 (0)2033 55 9889 (United Kingdom)
https://pulsarhelium.com
https://ca.linkedin.com/company/pulsar-helium-inc.

Strand Hanson Limited
(Nominated & Financial Adviser, and Broker)
Ritchie Balmer / Rob Patrick
+44 (0) 207 409 3494

Velocity Public Affairs
(Public Relations)
Stephanie Moncada / Mike Zipko
+ 1 (218) 203-5301
pulsarhelium@velocitypublicrelations.com

Yellow Jersey PR Limited
(Financial Public Relations)
Charles Goodwin / Annabelle Wills
+44 777 5194 357
pulsarhelium@yellowjerseypr.com

About Pulsar Helium Inc.

Pulsar Helium Inc. is a publicly traded company quoted on the AIM market of the London Stock Exchange (United Kingdom) and listed on the TSX Venture Exchange with the ticker PLSR (Canada), as well as on the OTCQB with the ticker PSRHF (United States of America). Pulsar’s portfolio consists of its flagship Topaz helium project in Minnesota, the Falcon project in Michigan (both in the USA), and the Tunu helium project in Greenland. Pulsar is the first mover in both locations with primary helium occurrences not associated with the production of hydrocarbons identified at each.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains forward-looking information within the meaning of applicable Canadian securities legislation (collectively, “forward-looking statements”) that relates to the Company’s current expectations and views of future events. Any statements that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance (often, but not always, through the use of words or phrases such as “will likely result”, “are expected to”, “expects”, “will continue”, “is anticipated”, “anticipates”, “believes”, “estimated”, “intends”, “plans”, “forecast”, “projection”, “strategy”, “objective” and “outlook”) are not historical facts and may be forward-looking statements. Forward-looking statements herein include, but are not limited to, statements relating to: the proposed acquisition of the Property and the timing and conditions of closing; the 365-day due diligence and project-commitment period; the satisfaction or waiver of closing conditions; the City’s financial participation, including the rail contribution, site clearing, utility extensions and City property-tax abatement; any tax abatements from Lake County and the Lake Superior School District; the negotiation and execution of the business subsidy, tax abatement, minimum assessment, electrical service, natural gas service and rail agreements; required zoning, land-use, rail and regulatory approvals; the proposed Rare Gas Hub, Plant and Facility, including their design, construction, phasing, expansion and proposed operation; the requirement to achieve commercial operation of the initial RGH phase within 36 months following formal project commitment, subject to permitted extensions; the acquisition of the Plant under the Equipment Reservation Letter Agreement; the Company’s financing plans; potential third-party gas processing services; and the anticipated benefits of the Project. Forward-looking statements may involve estimates and are based upon assumptions made by management of the Company, including, but not limited to, that the conditions to closing under the Agreement will be satisfied or waived within the applicable timeframe; that the related supporting agreements will be negotiated and executed on acceptable terms; that adequate electrical, natural gas, water and rail service will be available on acceptable terms; management’s expectations regarding the availability of capital to fund the Company’s future capital and operating requirements; the performance of the Plant and related equipment; and the ability to obtain all requisite regulatory approvals.

Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company’s control, which could cause actual results and events to differ materially from those disclosed in or implied by such forward-looking statements. Such risks and uncertainties include, but are not limited to: the risk that the conditions to closing under the Agreement are not satisfied or waived within the applicable timeframe or at all; the risk that Pulsar does not deliver a Project Commitment Notice and the Agreement is terminated; the risk that Pulsar may be unsuccessful in negotiating or executing supporting agreements relating to the business subsidy, tax abatement, minimum assessment, electrical service, natural gas service or rail arrangements on acceptable terms; the risk that the value of City assistance or any tax abatement is less than anticipated, or that Lake County or the Lake Superior School District do not approve any abatement; the risk that electrical capacity, upstream power-supply arrangements or any required regulatory approvals are not obtained on acceptable terms or within the anticipated timeframe; the risk that required rail access arrangements and approvals, including those involving Canadian National Railway, are not obtained; the risk that the City does not approve amendments to its zoning ordinance, site plans, construction plans, permits or other approvals required for the Company’s intended use of the Property; the risk that adequate financing is not available on acceptable terms or at all, and that any equity financing results in dilution to shareholders; the risk that the equipment to be acquired pursuant to the Equipment Reservation Letter Agreement may not perform as anticipated or at all; the risk that the Company does not secure third-party gas processing customers or feedstock; the absence of any economic feasibility study or comparable technical study supporting the Project; the risk of cost overruns and construction delays; the risk that required environmental review, permitting and implementation steps will not be completed; and other factors set forth above as well as risk factors included in the Company’s Annual Information Form dated February 3, 2026, for the year ended September 30, 2025, found under the Company’s profile on www.sedarplus.ca.

Forward-looking statements contained in this news release are as of the date of this news release, and the Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required by law. New factors emerge from time to time, and it is not possible for the Company to predict all of them or assess the impact of each such factor or the extent to which any factor, or combination of factors, may cause results to differ materially from those contained in any forward-looking statement. No assurance can be given that the forward-looking statements herein will prove to be correct and, accordingly, investors should not place undue reliance on forward-looking statements. Any forward-looking statements contained in this news release are expressly qualified in their entirety by this cautionary statement.

ICG Enterprise Trust plc (the “Company”)

20 October 2026

Transaction in Own Shares

The Company announces that on 19 October 2026 it bought back 10,000 of its own shares under the long-term buyback programme, to be held as treasury shares, at an average price of 1406 pence per share.

Further details are set out below:

  • Number of shares held as treasury shares following settlement of this purchase: 3,532,500
  • Total shares in issue excluding treasury shares following settlement of this purchase: 60,021,692

The Company has bought back these shares under the authority granted by shareholders at its Annual General Meeting in June 2026, which permits the Company to repurchase a maximum of 14.99% of its ordinary shares. The actual number of shares repurchased by the Company will depend on market conditions. This authority lasts until the next shareholder authority granted (expected to be at the Annual General Meeting in 2027), or until expressly revoked by shareholders.

No maximum consideration payable has been determined by the Company, but the Company is unable to pay a price for any shares pursuant to the buyback which would equate to a premium to the net asset value. It is the Company’s current intention to hold any shares bought back in treasury.

The Company has instructed Numis Securities Limited (trading for these purposes as Deutsche Numis) as its broker in respect of its buyback transactions. This arrangement is in accordance with the UKLA Listing Rules and the Company’s general authority to repurchase shares.

Analyst / Investor enquiries:

Chris Hunt
Shareholder Relations, ICG
+44 (0) 20 3545 2020

Andrew Lewis
Company Secretary, ICG
+44 (0) 20 3545 1344

Media:

Clare Glynn
Corporate Communications, ICG
+44 (0) 20 3545 1395

THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO AUSTRALIA, CANADA, ITALY, DENMARK, JAPAN, THE UNITED STATES, OR TO ANY NATIONAL OF SUCH JURISDICTIONS

Neuberger Private Equity Partners Announces Transaction in Own Shares

St Peter Port, Guernsey 20 October 2026

Neuberger Private Equity Partners Limited (“NBPE” or the “Company”) today announces details of Class A Shares bought back pursuant to general authority granted by shareholders of the Company on 11 June 2026 and the share buy-back agreement with Jefferies International Limited.

Transaction on London Stock Exchange

Date of purchase of Shares 19 October 2026
Number of Shares purchased 5,007 Class A Shares
Highest price/lowest price paid £15.02 / £14.94
ISIN for the Shares GG00B1ZBD492

All Class A Shares bought back will be cancelled. Following the cancellation, the number of outstanding Class A Shares is 37,016,964‬. The Company also has 3,150,408 Class A shares held in treasury. For reporting purposes under the FCA’s Disclosure Guidance and Transparency Rules the market should use the figure of 37,016,964 voting rights when determining if they are required to notify their interest in, or a change to their interest in the Company.

For further information, please contact:

NBPE Investor Relations        +44 20 3214 9002
Luke Mason        NBPrivateMarketsIR@nb.com

Oak Group        +44 1481 723450

        NBPEP@oak.group

About Neuberger Private Equity Partners Limited

Neuberger Private Equity Partners Limited (“NBPE”) invests in direct private equity investments alongside market leading private equity firms globally. NB Alternatives Advisers LLC (the “Investment Manager”), an indirect wholly owned subsidiary of Neuberger Berman Group LLC, is responsible for sourcing, execution and management of NBPE. The vast majority of direct investments are made with no management fee / no carried interest payable to third-party GPs, offering greater fee efficiency than other listed private equity companies. NBPE seeks capital appreciation through growth in net asset value over time while paying a bi-annual dividend.

LEI number: 213800UJH93NH8IOFQ77

About Neuberger

Neuberger was founded in 1939 to do one thing: deliver compelling investment results for our clients over the long term. This remains our singular purpose today, driven by a culture rooted in deep fundamental research, the pursuit of investment insight and continuous innovation on behalf of clients, and facilitated by the free exchange of ideas across the organization.

From offices in 39 cities[1] across 26 countries, Neuberger manages a range of equity, fixed income, private equity and hedge fund strategies on behalf of institutions, advisors and individual investors worldwide. With more than 780[1] investment professionals and over 2,900[1] employees in total, Neuberger has built a diverse team of individuals united in their commitment to client outcomes and investment excellence. Our culture has afforded us enviable retention rates among our senior investment staff and we are proud to have been ranked 1st by Pensions & Investments in their 2025 “Best Places to Work in Money Management” survey, where we have placed 1st in four of the last five years and finished in the top two for 12 consecutive years[2].

As a private, independent, employee-owned investment manager, Neuberger is structurally aligned with the long-term interests of our clients. We have no external parent or public shareholders to serve, nor other lines of business to distract us from our core mission. And with our employees and their families invested alongside our clients—plus 100% of employee deferred cash compensation directly linked to team and firm strategies—we are truly in this together.
For more information, please visit our website: www.nb.com/en/global/who-we-are.

Media Contacts:
US: Soogyung Jordan: Soogyung.Jordan@nb.com
EMEA: Fiona Kehily: Fiona.Kehily@nb.com

[1] Firm data reflects the collective data for the various subsidiaries of Neuberger Berman Group LLC as of 30 June 2026.

[2] Among organizations with over 1,000 employees by Pensions & Investments. For additional information on the criteria for the award, please visit https://www.pionline.com/awards/best-places-to-work-in-money-management/pi-best-places-to-work-2025.

This material is issued on a limited basis through various global subsidiaries and affiliates of Neuberger Berman Group LLC. Please visit www.nb.com/disclosure-global-communications to learn about each company and the legal restrictions and restrictions. The name “Neuberger Berman” and logo are registered service marks of Neuberger Berman Group LLC.

© 2026 Neuberger Berman Group LLC. All rights reserved.

This press release appears as a matter of record only and does not constitute an offer to sell or a solicitation of an offer to purchase any security.

NBPE is established as a closed-end investment company domiciled in Guernsey. NBPE has received the necessary consent of the Guernsey Financial Services Commission. The value of investments may fluctuate. Results achieved in the past are no guarantee of future results. This document is not intended to constitute legal, tax or accounting advice or investment recommendations. Prospective investors are advised to seek expert legal, financial, tax and other professional advice before making any investment decision. Statements contained in this document that are not historical facts are based on current expectations, estimates, projections, opinions and beliefs of NBPE’s investment manager. Such statements involve known and unknown risks, uncertainties and other factors, and undue reliance should not be placed thereon. Additionally, this document contains “forward-looking statements.” Actual events or results or the actual performance of NBPE may differ materially from those reflected or contemplated in such targets or forward-looking statements.

ENDEAVOUR ANNOUNCES TRANSACTION IN OWN SHARES

London, 20 October 2026 – Endeavour Mining plc (LSE:EDV, TSX:EDV, OTCQX:EDVMF) (“the Company”) announces it has purchased the following number of its ordinary shares of USD 0.01 each from Stifel Nicolaus Europe Limited.

Aggregated information

Date of Purchase Aggregate number of ordinary shares of USD 0.01 each purchased: Lowest price paid per share (GBp): Highest price paid per share (GBp): Volume weighted average price paid per share (GBp):
14 Oct 2026 9,045 3,956.00 4,141.00 4,008.39
15 Oct 2026 32,308 3,941.29 4,069.00 3,991.62
16 Oct 2026 39,432 4,110.00 4,220.00 4,167.00

Following the cancellation of the repurchased shares, the Company will have no ordinary shares in treasury and 241,544,937 ordinary shares in issue. Therefore, the total voting rights in the Company will be 241,544,937. This figure for the total number of voting rights may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA’s Disclosure Guidance and Transparency Rules.

These share purchases form part of the Company’s buy-back programme announced on 20 March 2026.

Transaction details

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), the table below contains detailed information of the individual trades made by Stifel Nicolaus Europe Limited as part of the buyback programme.

Schedule of purchases

Shares purchased:                Endeavour Mining plc (ISIN: GB00BL6K5J42)

Date of purchases:                Week commencing 12 October 2026

Investment firm:                  Stifel Nicolaus Europe Limited

Individual transactions

Transaction date and time Volume Price (GBp) Trading Venue
14 Oct 2026, 08:06 AM 112 4,137.00 LSE
14 Oct 2026, 08:07 AM 123 4,131.00 LSE
14 Oct 2026, 08:09 AM 114 4,131.00 LSE
14 Oct 2026, 08:11 AM 115 4,127.00 LSE
14 Oct 2026, 08:15 AM 135 4,135.00 LSE
14 Oct 2026, 08:16 AM 145 4,141.00 LSE
14 Oct 2026, 01:30 PM 54 4,127.00 LSE
14 Oct 2026, 01:30 PM 75 4,127.00 LSE
14 Oct 2026, 02:33 PM 129 4,063.00 LSE
14 Oct 2026, 02:33 PM 105 4,073.00 LSE
14 Oct 2026, 02:33 PM 30 4,073.00  LSE
14 Oct 2026, 02:33 PM 129 4,067.00 LSE
14 Oct 2026, 02:34 PM 31 4,064.00 LSE
14 Oct 2026, 02:34 PM 82 4,064.00 LSE
14 Oct 2026, 02:34 PM 129 4,063.00 LSE
14 Oct 2026, 02:34 PM 26 4,062.00 LSE
14 Oct 2026, 02:34 PM 43 4,062.00 LSE
14 Oct 2026, 02:34 PM 26 4,062.00 LSE
14 Oct 2026, 02:34 PM 26 4,061.00 LSE
14 Oct 2026, 02:35 PM 126 4,049.00 LSE
14 Oct 2026, 02:40 PM 8 4,037.00 LSE
14 Oct 2026, 02:40 PM 32 4,037.00 LSE
14 Oct 2026, 02:40 PM 80 4,037.00 LSE
14 Oct 2026, 02:40 PM 11 4,037.00 LSE
14 Oct 2026, 02:40 PM 61 4,036.00 LSE
14 Oct 2026, 02:40 PM 29 4,036.00 LSE
14 Oct 2026, 02:40 PM 24 4,036.00 LSE
14 Oct 2026, 02:40 PM 9 4,036.00 LSE
14 Oct 2026, 02:46 PM 114 4,019.00 LSE
14 Oct 2026, 02:46 PM 136 4,019.00 LSE
14 Oct 2026, 02:47 PM 125 4,017.00 LSE
14 Oct 2026, 02:47 PM 3 4,020.00 LSE
14 Oct 2026, 02:47 PM 63 4,020.00 LSE
14 Oct 2026, 02:47 PM 62 4,020.00 LSE
14 Oct 2026, 02:48 PM 128 4,020.00 LSE
14 Oct 2026, 02:48 PM 115 4,020.00 LSE
14 Oct 2026, 02:48 PM 125 4,019.00 LSE
14 Oct 2026, 02:49 PM 125 4,017.00 LSE
14 Oct 2026, 02:49 PM 26 4,015.00 LSE
14 Oct 2026, 02:51 PM 123 4,017.00 LSE
14 Oct 2026, 02:51 PM 111 4,018.00 LSE
14 Oct 2026, 02:53 PM 93 4,015.00 LSE
14 Oct 2026, 02:53 PM 32 4,015.00 LSE
14 Oct 2026, 02:59 PM 81 4,009.00 LSE
14 Oct 2026, 02:59 PM 32 4,009.00 LSE
14 Oct 2026, 02:59 PM 75 4,008.00 LSE
14 Oct 2026, 02:59 PM 44 4,008.00 LSE
14 Oct 2026, 03:32 PM 131 3,977.00 LSE
14 Oct 2026, 03:32 PM 133 3,976.00 LSE
14 Oct 2026, 03:35 PM 135 3,984.00 LSE
14 Oct 2026, 03:35 PM 132 3,991.00 LSE
14 Oct 2026, 03:36 PM 132 3,987.00 LSE
14 Oct 2026, 03:37 PM 129 3,982.00 LSE
14 Oct 2026, 03:38 PM 114 3,984.00 LSE
14 Oct 2026, 03:38 PM 114 3,989.00 LSE
14 Oct 2026, 03:38 PM 131 3,986.00 LSE
14 Oct 2026, 03:39 PM 116 3,975.00 LSE
14 Oct 2026, 03:41 PM 132 3,986.00 LSE
14 Oct 2026, 03:44 PM 136 4,004.00 LSE
14 Oct 2026, 03:45 PM 15 4,000.00 LSE
14 Oct 2026, 03:45 PM 116 4,000.00 LSE
14 Oct 2026, 03:47 PM 137 3,997.00 LSE
14 Oct 2026, 03:47 PM 134 3,995.00 LSE
14 Oct 2026, 03:49 PM 133 3,995.00 LSE
14 Oct 2026, 03:50 PM 112 3,985.00 LSE
14 Oct 2026, 03:51 PM 121 3,985.00 LSE
14 Oct 2026, 03:52 PM 120 3,986.00 LSE
14 Oct 2026, 03:52 PM 3 3,988.00 LSE
14 Oct 2026, 03:52 PM 7 3,988.00 LSE
14 Oct 2026, 03:52 PM 12 3,988.00 LSE
14 Oct 2026, 03:52 PM 100 3,988.00 LSE
14 Oct 2026, 03:53 PM 123 3,987.00 LSE
14 Oct 2026, 04:06 PM 112 3,976.00 LSE
14 Oct 2026, 04:06 PM 132 3,972.00 LSE
14 Oct 2026, 04:07 PM 137 3,967.00 LSE
14 Oct 2026, 04:07 PM 122 3,962.00 LSE
14 Oct 2026, 04:07 PM 126 3,961.00 LSE
14 Oct 2026, 04:07 PM 117 3,961.00 LSE
14 Oct 2026, 04:07 PM 125 3,960.00 LSE
14 Oct 2026, 04:07 PM 15 3,958.00 LSE
14 Oct 2026, 04:07 PM 104 3,958.00 LSE
14 Oct 2026, 04:07 PM 104 3,958.00 LSE
14 Oct 2026, 04:08 PM 9 3,957.00 LSE
14 Oct 2026, 04:08 PM 97 3,957.00 LSE
14 Oct 2026, 04:08 PM 17 3,957.00 LSE
14 Oct 2026, 04:08 PM 54 3,956.00 LSE
14 Oct 2026, 04:08 PM 76 3,956.00 LSE
14 Oct 2026, 04:11 PM 137 3,963.00 LSE
14 Oct 2026, 04:11 PM 1 3,960.00 LSE
14 Oct 2026, 04:11 PM 123 3,962.00 LSE
14 Oct 2026, 04:11 PM 19 3,958.00 LSE
14 Oct 2026, 04:11 PM 100 3,958.00 LSE
14 Oct 2026, 04:11 PM 89 3,958.00 LSE
14 Oct 2026, 04:11 PM 17 3,958.00 LSE
14 Oct 2026, 04:12 PM 48 3,958.00 LSE
14 Oct 2026, 04:13 PM 111 3,964.00 LSE
14 Oct 2026, 04:13 PM 34 3,965.00 LSE
14 Oct 2026, 04:13 PM 55 3,965.00 LSE
14 Oct 2026, 04:13 PM 34 3,964.00 LSE
14 Oct 2026, 04:14 PM 125 3,966.00 LSE
14 Oct 2026, 04:14 PM 135 3,965.00 LSE
14 Oct 2026, 04:14 PM 74 3,965.00 LSE
14 Oct 2026, 04:15 PM 116 3,973.00 LSE
14 Oct 2026, 04:16 PM 18 3,971.00 LSE
14 Oct 2026, 04:18 PM 40 3,975.00 LSE
14 Oct 2026, 04:18 PM 15 3,975.00 LSE
14 Oct 2026, 04:18 PM 56 3,975.00 LSE
14 Oct 2026, 04:18 PM 61 3,975.00 LSE
15 Oct 2026, 07:00 AM 15,400 3,941.29 TSX
15 Oct 2026, 08:03 AM 134 3,957.00 LSE
15 Oct 2026, 08:03 AM 114 3,952.00 LSE
15 Oct 2026, 08:04 AM 134 3,953.00 LSE
15 Oct 2026, 08:04 AM 130 3,951.00 LSE
15 Oct 2026, 08:04 AM 118 3,957.00 LSE
15 Oct 2026, 08:05 AM 126 3,966.00 LSE
15 Oct 2026, 08:07 AM 134 3,995.00 LSE
15 Oct 2026, 08:07 AM 132 3,993.00 LSE
15 Oct 2026, 08:07 AM 129 3,990.00 LSE
15 Oct 2026, 08:08 AM 124 3,996.00 LSE
15 Oct 2026, 08:08 AM 42 3,997.00 LSE
15 Oct 2026, 08:08 AM 94 3,997.00 LSE
15 Oct 2026, 08:12 AM 113 4,031.00 LSE
15 Oct 2026, 08:12 AM 128 4,030.00 LSE
15 Oct 2026, 08:18 AM 113 4,030.00 LSE
15 Oct 2026, 08:20 AM 133 4,023.00 LSE
15 Oct 2026, 08:21 AM 120 4,020.00 LSE
15 Oct 2026, 08:23 AM 76 4,012.00 LSE
15 Oct 2026, 08:23 AM 42 4,012.00 LSE
15 Oct 2026, 08:26 AM 132 4,026.00 LSE
15 Oct 2026, 08:27 AM 132 4,023.00 LSE
15 Oct 2026, 08:29 AM 15 4,020.00 LSE
15 Oct 2026, 08:29 AM 119 4,020.00 LSE
15 Oct 2026, 08:32 AM 132 4,040.00 LSE
15 Oct 2026, 08:33 AM 118 4,031.00 LSE
15 Oct 2026, 08:34 AM 114 4,024.00 LSE
15 Oct 2026, 08:36 AM 125 4,025.00 LSE
15 Oct 2026, 08:38 AM 116 4,037.00 LSE
15 Oct 2026, 08:47 AM 122 4,044.00 LSE
15 Oct 2026, 08:48 AM 111 4,041.00 LSE
15 Oct 2026, 08:51 AM 124 4,046.00 LSE
15 Oct 2026, 08:51 AM 12 4,046.00 LSE
15 Oct 2026, 08:51 AM 118 4,046.00 LSE
15 Oct 2026, 08:54 AM 119 4,049.00 LSE
15 Oct 2026, 08:54 AM 23 4,049.00 LSE
15 Oct 2026, 08:54 AM 58 4,049.00 LSE
15 Oct 2026, 08:54 AM 14 4,049.00 LSE
15 Oct 2026, 08:54 AM 14 4,049.00 LSE
15 Oct 2026, 08:54 AM 16 4,049.00 LSE
15 Oct 2026, 08:54 AM 133 4,043.00 LSE
15 Oct 2026, 09:00 AM 137 4,055.00 LSE
15 Oct 2026, 09:00 AM 119 4,054.00 LSE
15 Oct 2026, 09:21 AM 136 4,059.00 LSE
15 Oct 2026, 09:29 AM 119 4,064.00 LSE
15 Oct 2026, 09:39 AM 121 4,065.00 LSE
15 Oct 2026, 09:42 AM 137 4,062.00 LSE
15 Oct 2026, 09:49 AM 122 4,062.00 LSE
15 Oct 2026, 09:49 AM 80 4,063.00 LSE
15 Oct 2026, 09:50 AM 129 4,067.00 LSE
15 Oct 2026, 09:51 AM 112 4,069.00 LSE
15 Oct 2026, 09:51 AM 119 4,067.00 LSE
15 Oct 2026, 09:57 AM 112 4,060.00 LSE
15 Oct 2026, 09:57 AM 131 4,054.00 LSE
15 Oct 2026, 09:59 AM 135 4,050.00 LSE
15 Oct 2026, 10:04 AM 112 4,060.00 LSE
15 Oct 2026, 10:04 AM 123 4,060.00 LSE
15 Oct 2026, 10:05 AM 126 4,058.00 LSE
15 Oct 2026, 10:05 AM 133 4,052.00 LSE
15 Oct 2026, 10:06 AM 116 4,051.00 LSE
15 Oct 2026, 10:11 AM 131 4,053.00 LSE
15 Oct 2026, 10:12 AM 132 4,051.00 LSE
15 Oct 2026, 10:14 AM 119 4,056.00 LSE
15 Oct 2026, 10:15 AM 111 4,054.00 LSE
15 Oct 2026, 10:19 AM 116 4,054.00 LSE
15 Oct 2026, 10:24 AM 137 4,058.00 LSE
15 Oct 2026, 10:29 AM 133 4,058.00 LSE
15 Oct 2026, 10:32 AM 99 4,056.00 LSE
15 Oct 2026, 10:32 AM 36 4,056.00 LSE
15 Oct 2026, 10:34 AM 116 4,058.00 LSE
15 Oct 2026, 10:37 AM 134 4,059.00 LSE
15 Oct 2026, 10:40 AM 121 4,056.00 LSE
15 Oct 2026, 10:40 AM 85 4,055.00 LSE
15 Oct 2026, 10:40 AM 39 4,055.00 LSE
15 Oct 2026, 10:44 AM 129 4,056.00 LSE
15 Oct 2026, 10:44 AM 124 4,055.00 LSE
15 Oct 2026, 10:48 AM 128 4,050.00 LSE
15 Oct 2026, 10:48 AM 5 4,050.00 LSE
15 Oct 2026, 10:51 AM 121 4,051.00 LSE
15 Oct 2026, 10:53 AM 112 4,048.00 LSE
15 Oct 2026, 10:56 AM 9 4,049.00 LSE
15 Oct 2026, 10:56 AM 111 4,049.00 LSE
15 Oct 2026, 11:00 AM 136 4,046.00 LSE
15 Oct 2026, 11:03 AM 121 4,051.00 LSE
15 Oct 2026, 11:03 AM 117 4,049.00 LSE
15 Oct 2026, 11:08 AM 123 4,042.00 LSE
15 Oct 2026, 11:08 AM 12 4,038.00 LSE
15 Oct 2026, 11:08 AM 24 4,038.00 LSE
15 Oct 2026, 11:08 AM 32 4,038.00 LSE
15 Oct 2026, 11:11 AM 112 4,037.00 LSE
15 Oct 2026, 11:12 AM 119 4,037.00 LSE
15 Oct 2026, 11:18 AM 22 4,044.00 LSE
15 Oct 2026, 11:18 AM 129 4,044.00 LSE
15 Oct 2026, 11:18 AM 108 4,044.00 LSE
15 Oct 2026, 11:19 AM 136 4,038.00 LSE
15 Oct 2026, 11:23 AM 54 4,043.00 LSE
15 Oct 2026, 11:23 AM 60 4,043.00 LSE
15 Oct 2026, 11:26 AM 117 4,044.00 LSE
15 Oct 2026, 11:26 AM 141 4,043.00 LSE
15 Oct 2026, 11:28 AM 123 4,043.00 LSE
15 Oct 2026, 11:31 AM 94 4,046.00 LSE
15 Oct 2026, 11:31 AM 36 4,046.00 LSE
15 Oct 2026, 11:31 AM 121 4,044.00 LSE
15 Oct 2026, 11:35 AM 41 4,044.00 LSE
15 Oct 2026, 11:35 AM 86 4,044.00 LSE
15 Oct 2026, 11:40 AM 161 4,051.00 LSE
15 Oct 2026, 11:40 AM 17 4,051.00 LSE
15 Oct 2026, 11:42 AM 113 4,051.00 LSE
15 Oct 2026, 11:44 AM 115 4,050.00 LSE
15 Oct 2026, 11:52 AM 119 4,060.00 LSE
15 Oct 2026, 11:53 AM 137 4,058.00 LSE
15 Oct 2026, 11:54 AM 134 4,058.00 LSE
15 Oct 2026, 12:00 PM 135 4,058.00 LSE
15 Oct 2026, 12:00 PM 7 4,058.00 LSE
15 Oct 2026, 12:00 PM 12 4,058.00 LSE
15 Oct 2026, 12:00 PM 100 4,058.00 LSE
15 Oct 2026, 12:08 PM 4 4,056.00 LSE
15 Oct 2026, 12:08 PM 84 4,056.00 LSE
15 Oct 2026, 12:08 PM 46 4,056.00 LSE
15 Oct 2026, 12:18 PM 121 4,053.00 LSE
15 Oct 2026, 12:18 PM 43 4,054.00 LSE
15 Oct 2026, 12:18 PM 47 4,054.00 LSE
15 Oct 2026, 12:18 PM 18 4,053.00 LSE
15 Oct 2026, 12:18 PM 22 4,053.00 LSE
15 Oct 2026, 12:21 PM 117 4,049.00 LSE
15 Oct 2026, 12:21 PM 19 4,048.00 LSE
15 Oct 2026, 12:21 PM 100 4,048.00 LSE
15 Oct 2026, 12:23 PM 122 4,054.00 LSE
15 Oct 2026, 12:26 PM 123 4,058.00 LSE
15 Oct 2026, 12:26 PM 111 4,058.00 LSE
15 Oct 2026, 12:51 PM 116 4,050.00 LSE
15 Oct 2026, 01:02 PM 78 4,050.00 LSE
15 Oct 2026, 01:02 PM 34 4,050.00 LSE
15 Oct 2026, 01:10 PM 15 4,050.00 LSE
15 Oct 2026, 01:13 PM 7 4,050.00 LSE
15 Oct 2026, 01:30 PM 121 4,040.00 LSE
15 Oct 2026, 02:31 PM 13 4,040.00 LSE
15 Oct 2026, 02:31 PM 59 4,040.00 LSE
15 Oct 2026, 02:31 PM 53 4,040.00 LSE
15 Oct 2026, 02:31 PM 76 4,038.00 LSE
15 Oct 2026, 02:32 PM 120 4,039.00 LSE
15 Oct 2026, 02:33 PM 121 4,040.00 LSE
15 Oct 2026, 02:33 PM 117 4,039.00 LSE
15 Oct 2026, 02:33 PM 16 4,039.00 LSE
15 Oct 2026, 02:33 PM 117 4,040.00 LSE
15 Oct 2026, 02:34 PM 119 4,039.00 LSE
15 Oct 2026, 02:44 PM 69 4,030.00 LSE
15 Oct 2026, 02:44 PM 139 4,029.00 LSE
15 Oct 2026, 02:44 PM 133 4,028.00 LSE
15 Oct 2026, 02:45 PM 25 4,018.00 LSE
15 Oct 2026, 02:45 PM 102 4,018.00 LSE
15 Oct 2026, 02:46 PM 110 4,018.00 LSE
15 Oct 2026, 02:46 PM 21 4,018.00 LSE
15 Oct 2026, 02:46 PM 121 4,017.00 LSE
15 Oct 2026, 02:47 PM 124 4,028.00 LSE
15 Oct 2026, 02:49 PM 118 4,030.00 LSE
15 Oct 2026, 02:49 PM 20 4,030.00 LSE
15 Oct 2026, 02:49 PM 96 4,030.00 LSE
15 Oct 2026, 02:49 PM 113 4,030.00 LSE
15 Oct 2026, 02:49 PM 139 4,030.00 LSE
15 Oct 2026, 02:50 PM 111 4,028.00 LSE
15 Oct 2026, 02:50 PM 132 4,025.00 LSE
15 Oct 2026, 02:50 PM 38 4,024.00 LSE
15 Oct 2026, 02:50 PM 77 4,024.00 LSE
15 Oct 2026, 02:50 PM 40 4,024.00 LSE
15 Oct 2026, 02:51 PM 134 4,023.00 LSE
15 Oct 2026, 02:53 PM 95 4,024.00 LSE
15 Oct 2026, 02:53 PM 42 4,024.00 LSE
15 Oct 2026, 02:53 PM 62 4,023.00 LSE
15 Oct 2026, 02:53 PM 59 4,023.00 LSE
15 Oct 2026, 02:53 PM 40 4,021.00 LSE
15 Oct 2026, 02:53 PM 137 4,023.00 LSE
15 Oct 2026, 02:54 PM 69 4,025.00 LSE
15 Oct 2026, 02:54 PM 65 4,025.00 LSE
15 Oct 2026, 02:54 PM 158 4,024.00 LSE
15 Oct 2026, 02:54 PM 95 4,023.00 LSE
15 Oct 2026, 02:54 PM 17 4,023.00 LSE
15 Oct 2026, 02:54 PM 124 4,021.00 LSE
15 Oct 2026, 02:55 PM 111 4,024.00 LSE
15 Oct 2026, 02:56 PM 129 4,025.00 LSE
16 Oct 2026, 08:02 AM 22 4,146.00 LSE
16 Oct 2026, 08:02 AM 101 4,146.00 LSE
16 Oct 2026, 08:07 AM 116 4,138.00 LSE
16 Oct 2026, 08:07 AM 127 4,139.00 LSE
16 Oct 2026, 08:09 AM 112 4,128.00 LSE
16 Oct 2026, 08:10 AM 117 4,125.00 LSE
16 Oct 2026, 08:15 AM 186 4,137.00 LSE
16 Oct 2026, 08:15 AM 129 4,133.00 LSE
16 Oct 2026, 08:15 AM 120 4,144.00 LSE
16 Oct 2026, 08:16 AM 112 4,146.00 LSE
16 Oct 2026, 08:16 AM 115 4,141.00 LSE
16 Oct 2026, 08:17 AM 116 4,144.00 LSE
16 Oct 2026, 08:19 AM 130 4,141.00 LSE
16 Oct 2026, 08:19 AM 109 4,140.00 LSE
16 Oct 2026, 08:19 AM 107 4,138.00 LSE
16 Oct 2026, 08:21 AM 21 4,132.00 LSE
16 Oct 2026, 08:21 AM 105 4,132.00 LSE
16 Oct 2026, 08:21 AM 54 4,131.00 LSE
16 Oct 2026, 08:21 AM 73 4,131.00 LSE
16 Oct 2026, 08:23 AM 129 4,129.00 LSE
16 Oct 2026, 08:25 AM 129 4,131.00 LSE
16 Oct 2026, 08:29 AM 42 4,122.00 LSE
16 Oct 2026, 08:29 AM 66 4,122.00 LSE
16 Oct 2026, 08:29 AM 115 4,123.00 LSE
16 Oct 2026, 08:30 AM 11 4,125.00 LSE
16 Oct 2026, 08:30 AM 1 4,125.00 LSE
16 Oct 2026, 08:30 AM 13 4,125.00 LSE
16 Oct 2026, 08:30 AM 92 4,125.00 LSE
16 Oct 2026, 08:30 AM 1 4,125.00 LSE
16 Oct 2026, 08:32 AM 4 4,126.00 LSE
16 Oct 2026, 08:32 AM 8 4,126.00 LSE
16 Oct 2026, 08:32 AM 16 4,126.00 LSE
16 Oct 2026, 08:32 AM 16 4,126.00 LSE
16 Oct 2026, 08:32 AM 8 4,126.00 LSE
16 Oct 2026, 08:33 AM 130 4,128.00 LSE
16 Oct 2026, 08:37 AM 17 4,126.00 LSE
16 Oct 2026, 08:37 AM 101 4,126.00 LSE
16 Oct 2026, 08:40 AM 1 4,121.00 LSE
16 Oct 2026, 08:41 AM 78 4,121.00 LSE
16 Oct 2026, 08:41 AM 18 4,121.00 LSE
16 Oct 2026, 08:41 AM 6 4,121.00 LSE
16 Oct 2026, 08:41 AM 18 4,121.00 LSE
16 Oct 2026, 08:41 AM 6 4,121.00 LSE
16 Oct 2026, 08:43 AM 126 4,130.00 LSE
16 Oct 2026, 08:45 AM 107 4,114.00 LSE
16 Oct 2026, 08:46 AM 38 4,112.00 LSE
16 Oct 2026, 08:46 AM 5 4,112.00 LSE
16 Oct 2026, 08:46 AM 24 4,112.00 LSE
16 Oct 2026, 08:46 AM 24 4,112.00 LSE
16 Oct 2026, 08:47 AM 115 4,110.00 LSE
16 Oct 2026, 08:49 AM 121 4,118.00 LSE
16 Oct 2026, 08:51 AM 116 4,116.00 LSE
16 Oct 2026, 08:52 AM 126 4,123.00 LSE
16 Oct 2026, 08:53 AM 120 4,121.00 LSE
16 Oct 2026, 08:58 AM 124 4,131.00 LSE
16 Oct 2026, 09:01 AM 35 4,127.00 LSE
16 Oct 2026, 09:01 AM 106 4,128.00 LSE
16 Oct 2026, 09:04 AM 128 4,135.00 LSE
16 Oct 2026, 09:08 AM 108 4,137.00 LSE
16 Oct 2026, 09:09 AM 127 4,137.00 LSE
16 Oct 2026, 09:13 AM 129 4,134.00 LSE
16 Oct 2026, 09:14 AM 122 4,138.00 LSE
16 Oct 2026, 09:15 AM 116 4,138.00 LSE
16 Oct 2026, 09:18 AM 81 4,128.00 LSE
16 Oct 2026, 09:18 AM 2 4,128.00 LSE
16 Oct 2026, 09:18 AM 24 4,128.00 LSE
16 Oct 2026, 09:24 AM 3 4,147.00 LSE
16 Oct 2026, 09:24 AM 116 4,147.00 LSE
16 Oct 2026, 09:24 AM 2 4,146.00 LSE
16 Oct 2026, 09:24 AM 24 4,146.00 LSE
16 Oct 2026, 09:26 AM 124 4,149.00 LSE
16 Oct 2026, 09:27 AM 115 4,148.00 LSE
16 Oct 2026, 09:32 AM 130 4,155.00 LSE
16 Oct 2026, 09:32 AM 115 4,152.00 LSE
16 Oct 2026, 09:32 AM 109 4,150.00 LSE
16 Oct 2026, 09:41 AM 126 4,159.00 LSE
16 Oct 2026, 09:44 AM 132 4,161.00 LSE
16 Oct 2026, 09:45 AM 132 4,165.00 LSE
16 Oct 2026, 09:45 AM 122 4,164.00 LSE
16 Oct 2026, 09:46 AM 112 4,165.00 LSE
16 Oct 2026, 09:47 AM 123 4,159.00 LSE
16 Oct 2026, 09:52 AM 128 4,155.00 LSE
16 Oct 2026, 09:53 AM 107 4,155.00 LSE
16 Oct 2026, 09:54 AM 6 4,153.00 LSE
16 Oct 2026, 09:54 AM 129 4,153.00 LSE
16 Oct 2026, 09:55 AM 131 4,158.00 LSE
16 Oct 2026, 09:55 AM 24 4,156.00 LSE
16 Oct 2026, 09:57 AM 3 4,156.00 LSE
16 Oct 2026, 09:57 AM 21 4,156.00 LSE
16 Oct 2026, 09:58 AM 103 4,156.00 LSE
16 Oct 2026, 09:59 AM 123 4,154.00 LSE
16 Oct 2026, 10:00 AM 125 4,149.00 LSE
16 Oct 2026, 10:03 AM 107 4,151.00 LSE
16 Oct 2026, 10:04 AM 122 4,152.00 LSE
16 Oct 2026, 10:07 AM 87 4,159.00 LSE
16 Oct 2026, 10:09 AM 19 4,159.00 LSE
16 Oct 2026, 10:15 AM 467 4,166.00 LSE
16 Oct 2026, 10:15 AM 13 4,168.00 LSE
16 Oct 2026, 10:15 AM 217 4,168.00 LSE
16 Oct 2026, 10:15 AM 110 4,165.00 LSE
16 Oct 2026, 10:15 AM 114 4,164.00 LSE
16 Oct 2026, 10:16 AM 10 4,160.00 LSE
16 Oct 2026, 10:16 AM 24 4,160.00 LSE
16 Oct 2026, 10:16 AM 24 4,160.00 LSE
16 Oct 2026, 10:16 AM 126 4,160.00 LSE
16 Oct 2026, 10:18 AM 122 4,158.00 LSE
16 Oct 2026, 10:18 AM 112 4,155.00 LSE
16 Oct 2026, 10:22 AM 114 4,152.00 LSE
16 Oct 2026, 10:23 AM 115 4,152.00 LSE
16 Oct 2026, 10:23 AM 21 4,153.00 LSE
16 Oct 2026, 10:23 AM 89 4,153.00 LSE
16 Oct 2026, 10:26 AM 124 4,152.00 LSE
16 Oct 2026, 10:27 AM 122 4,152.00 LSE
16 Oct 2026, 10:29 AM 42 4,152.00 LSE
16 Oct 2026, 10:29 AM 67 4,152.00 LSE
16 Oct 2026, 10:31 AM 108 4,146.00 LSE
16 Oct 2026, 10:34 AM 125 4,147.00 LSE
16 Oct 2026, 10:34 AM 115 4,147.00 LSE
16 Oct 2026, 10:38 AM 110 4,151.00 LSE
16 Oct 2026, 10:45 AM 115 4,144.00 LSE
16 Oct 2026, 10:47 AM 110 4,150.00 LSE
16 Oct 2026, 10:50 AM 39 4,152.00 LSE
16 Oct 2026, 10:52 AM 42 4,155.00 LSE
16 Oct 2026, 10:52 AM 80 4,155.00 LSE
16 Oct 2026, 11:02 AM 113 4,151.00 LSE
16 Oct 2026, 11:02 AM 16 4,150.00 LSE
16 Oct 2026, 11:06 AM 118 4,150.00 LSE
16 Oct 2026, 11:09 AM 118 4,155.00 LSE
16 Oct 2026, 11:09 AM 182 4,158.00 LSE
16 Oct 2026, 11:09 AM 129 4,159.00 LSE
16 Oct 2026, 11:15 AM 29 4,165.00 LSE
16 Oct 2026, 11:15 AM 107 4,164.00 LSE
16 Oct 2026, 11:25 AM 1 4,168.00 LSE
16 Oct 2026, 11:25 AM 24 4,168.00 LSE
16 Oct 2026, 11:25 AM 132 4,170.00 LSE
16 Oct 2026, 11:32 AM 131 4,170.00 LSE
16 Oct 2026, 11:35 AM 116 4,169.00 LSE
16 Oct 2026, 11:40 AM 127 4,168.00 LSE
16 Oct 2026, 11:43 AM 130 4,161.00 LSE
16 Oct 2026, 11:45 AM 127 4,164.00 LSE
16 Oct 2026, 11:50 AM 120 4,160.00 LSE
16 Oct 2026, 11:52 AM 124 4,159.00 LSE
16 Oct 2026, 11:53 AM 106 4,163.00 LSE
16 Oct 2026, 11:54 AM 28 4,156.00 LSE
16 Oct 2026, 11:54 AM 44 4,156.00 LSE
16 Oct 2026, 11:54 AM 15 4,157.00 LSE
16 Oct 2026, 11:54 AM 46 4,156.00 LSE
16 Oct 2026, 11:54 AM 39 4,156.00 LSE
16 Oct 2026, 11:54 AM 82 4,152.00 LSE
16 Oct 2026, 11:54 AM 50 4,152.00 LSE
16 Oct 2026, 12:00 PM 163 4,151.00 LSE
16 Oct 2026, 12:00 PM 125 4,149.00 LSE
16 Oct 2026, 12:00 PM 106 4,148.00 LSE
16 Oct 2026, 12:01 PM 76 4,147.00 LSE
16 Oct 2026, 12:01 PM 110 4,146.00 LSE
16 Oct 2026, 12:07 PM 108 4,141.00 LSE
16 Oct 2026, 12:07 PM 28 4,142.00 LSE
16 Oct 2026, 12:07 PM 80 4,142.00 LSE
16 Oct 2026, 12:09 PM 6 4,140.00 LSE
16 Oct 2026, 12:09 PM 123 4,140.00 LSE
16 Oct 2026, 12:14 PM 126 4,140.00 LSE
16 Oct 2026, 12:19 PM 127 4,145.00 LSE
16 Oct 2026, 12:20 PM 33 4,143.00 LSE
16 Oct 2026, 12:20 PM 125 4,141.00 LSE
16 Oct 2026, 12:24 PM 24 4,139.00 LSE
16 Oct 2026, 12:25 PM 114 4,140.00 LSE
16 Oct 2026, 12:30 PM 120 4,138.00 LSE
16 Oct 2026, 12:31 PM 32 4,136.00 LSE
16 Oct 2026, 12:31 PM 93 4,136.00 LSE
16 Oct 2026, 12:33 PM 108 4,134.00 LSE
16 Oct 2026, 12:36 PM 14 4,137.00 LSE
16 Oct 2026, 12:36 PM 107 4,137.00 LSE
16 Oct 2026, 12:40 PM 28 4,138.00 LSE
16 Oct 2026, 12:40 PM 103 4,138.00 LSE
16 Oct 2026, 12:42 PM 120 4,139.00 LSE
16 Oct 2026, 12:45 PM 127 4,138.00 LSE
16 Oct 2026, 12:50 PM 120 4,135.00 LSE
16 Oct 2026, 12:53 PM 95 4,131.00 LSE
16 Oct 2026, 12:53 PM 23 4,131.00 LSE
16 Oct 2026, 12:53 PM 1 4,131.00 LSE
16 Oct 2026, 12:56 PM 9 4,129.00 LSE
16 Oct 2026, 12:56 PM 24 4,129.00 LSE
16 Oct 2026, 12:57 PM 108 4,128.00 LSE
16 Oct 2026, 12:57 PM 35 4,128.00 LSE
16 Oct 2026, 01:03 PM 129 4,118.00 LSE
16 Oct 2026, 01:04 PM 128 4,119.00 LSE
16 Oct 2026, 01:08 PM 2 4,125.00 LSE
16 Oct 2026, 01:08 PM 24 4,125.00 LSE
16 Oct 2026, 01:08 PM 125 4,123.00 LSE
16 Oct 2026, 01:11 PM 121 4,127.00 LSE
16 Oct 2026, 01:12 PM 2 4,126.00 LSE
16 Oct 2026, 01:12 PM 24 4,126.00 LSE
16 Oct 2026, 01:12 PM 128 4,122.00 LSE
16 Oct 2026, 01:14 PM 125 4,122.00 LSE
16 Oct 2026, 01:25 PM 122 4,134.00 LSE
16 Oct 2026, 01:25 PM 24 4,132.00 LSE
16 Oct 2026, 01:29 PM 115 4,130.00 LSE
16 Oct 2026, 01:31 PM 116 4,133.00 LSE
16 Oct 2026, 01:32 PM 109 4,134.00 LSE
16 Oct 2026, 01:37 PM 21 4,140.00 LSE
16 Oct 2026, 01:37 PM 90 4,140.00 LSE
16 Oct 2026, 01:42 PM 91 4,137.00 LSE
16 Oct 2026, 01:42 PM 1 4,137.00 LSE
16 Oct 2026, 01:45 PM 2 4,135.00 LSE
16 Oct 2026, 01:45 PM 24 4,135.00 LSE
16 Oct 2026, 01:47 PM 15 4,138.00 LSE
16 Oct 2026, 01:47 PM 116 4,138.00 LSE
16 Oct 2026, 01:47 PM 106 4,137.00 LSE
16 Oct 2026, 01:53 PM 108 4,134.00 LSE
16 Oct 2026, 01:53 PM 67 4,133.00 LSE
16 Oct 2026, 01:53 PM 49 4,133.00 LSE
16 Oct 2026, 01:54 PM 119 4,134.00 LSE
16 Oct 2026, 01:54 PM 110 4,135.00 LSE
16 Oct 2026, 01:54 PM 13 4,135.00 LSE
16 Oct 2026, 01:55 PM 119 4,134.00 LSE
16 Oct 2026, 01:55 PM 3 4,134.00 LSE
16 Oct 2026, 01:57 PM 111 4,129.00 LSE
16 Oct 2026, 01:58 PM 109 4,126.00 LSE
16 Oct 2026, 01:58 PM 22 4,126.00 LSE
16 Oct 2026, 02:00 PM 131 4,134.00 LSE
16 Oct 2026, 02:00 PM 20 4,143.00 LSE
16 Oct 2026, 02:00 PM 90 4,143.00 LSE
16 Oct 2026, 02:01 PM 113 4,143.00 LSE
16 Oct 2026, 02:07 PM 112 4,149.00 LSE
16 Oct 2026, 02:09 PM 132 4,143.00 LSE
16 Oct 2026, 02:15 PM 64 4,137.00 LSE
16 Oct 2026, 02:15 PM 55 4,137.00 LSE
16 Oct 2026, 02:17 PM 94 4,129.00 LSE
16 Oct 2026, 02:17 PM 4 4,129.00 LSE
16 Oct 2026, 02:17 PM 20 4,129.00 LSE
16 Oct 2026, 02:18 PM 118 4,129.00 LSE
16 Oct 2026, 02:21 PM 65 4,128.00 LSE
16 Oct 2026, 02:21 PM 52 4,128.00 LSE
16 Oct 2026, 02:23 PM 115 4,125.00 LSE
16 Oct 2026, 02:26 PM 111 4,125.00 LSE
16 Oct 2026, 02:26 PM 12 4,125.00 LSE
16 Oct 2026, 02:28 PM 44 4,131.00 LSE
16 Oct 2026, 02:28 PM 122 4,131.00 LSE
16 Oct 2026, 02:29 PM 44 4,139.00 LSE
16 Oct 2026, 02:29 PM 125 4,139.00 LSE
16 Oct 2026, 02:29 PM 98 4,139.00 LSE
16 Oct 2026, 02:31 PM 108 4,146.00 LSE
16 Oct 2026, 02:31 PM 124 4,145.00 LSE
16 Oct 2026, 02:31 PM 119 4,146.00 LSE
16 Oct 2026, 02:31 PM 107 4,144.00 LSE
16 Oct 2026, 02:31 PM 21 4,144.00 LSE
16 Oct 2026, 02:31 PM 116 4,142.00 LSE
16 Oct 2026, 02:32 PM 85 4,136.00 LSE
16 Oct 2026, 02:32 PM 37 4,136.00 LSE
16 Oct 2026, 02:32 PM 8 4,136.00 LSE
16 Oct 2026, 02:32 PM 100 4,127.00 LSE
16 Oct 2026, 02:32 PM 22 4,127.00 LSE
16 Oct 2026, 02:32 PM 132 4,130.00 LSE
16 Oct 2026, 02:32 PM 251 4,132.00 LSE
16 Oct 2026, 02:32 PM 64 4,130.00 LSE
16 Oct 2026, 02:32 PM 53 4,130.00 LSE
16 Oct 2026, 02:32 PM 48 4,131.00 LSE
16 Oct 2026, 02:32 PM 72 4,131.00 LSE
16 Oct 2026, 02:32 PM 6 4,136.00 LSE
16 Oct 2026, 02:32 PM 71 4,136.00 LSE
16 Oct 2026, 02:32 PM 56 4,136.00 LSE
16 Oct 2026, 02:33 PM 130 4,136.00 LSE
16 Oct 2026, 02:33 PM 127 4,146.00 LSE
16 Oct 2026, 02:54 PM 58 4,187.00 LSE
16 Oct 2026, 02:54 PM 62 4,187.00 LSE
16 Oct 2026, 02:54 PM 110 4,187.00 LSE
16 Oct 2026, 02:54 PM 37 4,187.00 LSE
16 Oct 2026, 02:54 PM 69 4,187.00 LSE
16 Oct 2026, 02:54 PM 37 4,187.00 LSE
16 Oct 2026, 02:55 PM 126 4,184.00 LSE
16 Oct 2026, 02:56 PM 122 4,183.00 LSE
16 Oct 2026, 02:56 PM 10 4,187.00 LSE
16 Oct 2026, 02:56 PM 103 4,187.00 LSE
16 Oct 2026, 02:56 PM 4 4,187.00 LSE
16 Oct 2026, 02:56 PM 21 4,186.00 LSE
16 Oct 2026, 02:56 PM 88 4,186.00 LSE
16 Oct 2026, 02:57 PM 88 4,187.00 LSE
16 Oct 2026, 02:57 PM 44 4,187.00 LSE
16 Oct 2026, 02:57 PM 37 4,183.00 LSE
16 Oct 2026, 02:57 PM 83 4,183.00 LSE
16 Oct 2026, 02:58 PM 103 4,187.00 LSE
16 Oct 2026, 02:58 PM 72 4,183.00 LSE
16 Oct 2026, 02:58 PM 53 4,183.00 LSE
16 Oct 2026, 02:59 PM 94 4,183.00 LSE
16 Oct 2026, 02:59 PM 128 4,181.00 LSE
16 Oct 2026, 03:00 PM 127 4,179.00 LSE
16 Oct 2026, 03:00 PM 120 4,189.00 LSE
16 Oct 2026, 03:00 PM 1 4,182.00 LSE
16 Oct 2026, 03:00 PM 144 4,182.00 LSE
16 Oct 2026, 03:00 PM 12 4,182.00 LSE
16 Oct 2026, 03:00 PM 104 4,182.00 LSE
16 Oct 2026, 03:00 PM 94 4,188.00 LSE
16 Oct 2026, 03:00 PM 95 4,189.00 LSE
16 Oct 2026, 03:01 PM 75 4,190.00 LSE
16 Oct 2026, 03:01 PM 40 4,190.00 LSE
16 Oct 2026, 03:01 PM 132 4,184.00 LSE
16 Oct 2026, 03:01 PM 19 4,184.00 LSE
16 Oct 2026, 03:01 PM 112 4,184.00 LSE
16 Oct 2026, 03:02 PM 122 4,188.00 LSE
16 Oct 2026, 03:02 PM 72 4,181.00 LSE
16 Oct 2026, 03:02 PM 58 4,181.00 LSE
16 Oct 2026, 03:02 PM 122 4,185.00 LSE
16 Oct 2026, 03:03 PM 111 4,180.00 LSE
16 Oct 2026, 03:03 PM 31 4,180.00 LSE
16 Oct 2026, 03:03 PM 89 4,180.00 LSE
16 Oct 2026, 03:03 PM 3 4,180.00 LSE
16 Oct 2026, 03:03 PM 33 4,180.00 LSE
16 Oct 2026, 03:03 PM 90 4,180.00 LSE
16 Oct 2026, 03:04 PM 108 4,177.00 LSE
16 Oct 2026, 03:04 PM 118 4,169.00 LSE
16 Oct 2026, 03:04 PM 1 4,169.00 LSE
16 Oct 2026, 03:06 PM 117 4,169.00 LSE
16 Oct 2026, 03:07 PM 128 4,172.00 LSE
16 Oct 2026, 03:07 PM 2 4,172.00 LSE
16 Oct 2026, 03:07 PM 24 4,172.00 LSE
16 Oct 2026, 03:07 PM 36 4,172.00 LSE
16 Oct 2026, 03:07 PM 18 4,180.00 LSE
16 Oct 2026, 03:07 PM 115 4,179.00 LSE
16 Oct 2026, 03:08 PM 107 4,182.00 LSE
16 Oct 2026, 03:10 PM 113 4,189.00 LSE
16 Oct 2026, 03:11 PM 107 4,190.00 LSE
16 Oct 2026, 03:12 PM 96 4,190.00 LSE
16 Oct 2026, 03:12 PM 36 4,190.00 LSE
16 Oct 2026, 03:14 PM 119 4,188.00 LSE
16 Oct 2026, 03:14 PM 44 4,188.00 LSE
16 Oct 2026, 03:14 PM 79 4,188.00 LSE
16 Oct 2026, 03:30 PM 50 4,215.00 LSE
16 Oct 2026, 03:30 PM 79 4,215.00 LSE
16 Oct 2026, 03:31 PM 112 4,218.00 LSE
16 Oct 2026, 03:32 PM 122 4,220.00 LSE
16 Oct 2026, 03:33 PM 27 4,215.00 LSE
16 Oct 2026, 03:33 PM 55 4,215.00 LSE
16 Oct 2026, 03:33 PM 3 4,215.00 LSE
16 Oct 2026, 03:33 PM 117 4,216.00 LSE
16 Oct 2026, 03:35 PM 123 4,210.00 LSE
16 Oct 2026, 03:35 PM 37 4,207.00 LSE
16 Oct 2026, 03:35 PM 89 4,207.00 LSE
16 Oct 2026, 03:35 PM 10 4,209.00 LSE
16 Oct 2026, 03:35 PM 103 4,209.00 LSE
16 Oct 2026, 03:35 PM 135 4,210.00 LSE
16 Oct 2026, 03:36 PM 88 4,209.00 LSE
16 Oct 2026, 03:36 PM 116 4,207.00 LSE
16 Oct 2026, 03:36 PM 73 4,204.00 LSE
16 Oct 2026, 03:36 PM 56 4,204.00 LSE
16 Oct 2026, 03:37 PM 127 4,202.00 LSE
16 Oct 2026, 03:37 PM 106 4,202.00 LSE
16 Oct 2026, 03:38 PM 126 4,204.00 LSE
16 Oct 2026, 03:38 PM 109 4,203.00 LSE
16 Oct 2026, 03:39 PM 107 4,199.00 LSE
16 Oct 2026, 03:41 PM 14 4,200.00 LSE
16 Oct 2026, 03:41 PM 79 4,200.00 LSE
16 Oct 2026, 03:41 PM 18 4,200.00 LSE
16 Oct 2026, 03:42 PM 103 4,209.00 LSE
16 Oct 2026, 03:42 PM 14 4,209.00 LSE
16 Oct 2026, 03:43 PM 119 4,205.00 LSE
16 Oct 2026, 03:45 PM 119 4,201.00 LSE
16 Oct 2026, 03:46 PM 126 4,203.00 LSE
16 Oct 2026, 03:47 PM 24 4,206.00 LSE
16 Oct 2026, 03:48 PM 117 4,207.00 LSE
16 Oct 2026, 03:49 PM 108 4,206.00 LSE
16 Oct 2026, 03:51 PM 129 4,213.00 LSE
16 Oct 2026, 03:51 PM 5 4,218.00 LSE
16 Oct 2026, 03:51 PM 128 4,216.00 LSE
16 Oct 2026, 03:53 PM 126 4,215.00 LSE
16 Oct 2026, 03:55 PM 111 4,220.00 LSE
16 Oct 2026, 03:56 PM 44 4,216.00 LSE
16 Oct 2026, 03:56 PM 80 4,216.00 LSE
16 Oct 2026, 03:58 PM 33 4,214.00 LSE
16 Oct 2026, 03:58 PM 80 4,214.00 LSE
16 Oct 2026, 03:58 PM 66 4,215.00 LSE
16 Oct 2026, 03:58 PM 70 4,215.00 LSE
16 Oct 2026, 03:58 PM 35 4,214.00 LSE
16 Oct 2026, 03:58 PM 80 4,214.00 LSE
16 Oct 2026, 03:58 PM 108 4,212.00 LSE
16 Oct 2026, 04:00 PM 115 4,211.00 LSE
16 Oct 2026, 04:01 PM 34 4,208.00 LSE
16 Oct 2026, 04:01 PM 80 4,208.00 LSE
16 Oct 2026, 04:01 PM 106 4,207.00 LSE
16 Oct 2026, 04:03 PM 113 4,211.00 LSE
16 Oct 2026, 04:04 PM 122 4,212.00 LSE
16 Oct 2026, 04:06 PM 87 4,212.00 LSE
16 Oct 2026, 04:06 PM 43 4,212.00 LSE
16 Oct 2026, 04:06 PM 92 4,210.00 LSE
16 Oct 2026, 04:06 PM 27 4,210.00 LSE
16 Oct 2026, 04:07 PM 109 4,209.00 LSE
16 Oct 2026, 04:07 PM 12 4,209.00 LSE
16 Oct 2026, 04:07 PM 119 4,209.00 LSE
16 Oct 2026, 04:07 PM 59 4,206.00 LSE
16 Oct 2026, 04:08 PM 90 4,207.00 LSE
16 Oct 2026, 04:08 PM 28 4,207.00 LSE
16 Oct 2026, 04:10 PM 108 4,208.00 LSE
16 Oct 2026, 04:10 PM 112 4,206.00 LSE
16 Oct 2026, 04:11 PM 76 4,202.00 LSE
16 Oct 2026, 04:11 PM 48 4,202.00 LSE
16 Oct 2026, 04:13 PM 124 4,205.00 LSE
16 Oct 2026, 04:13 PM 80 4,203.00 LSE
16 Oct 2026, 04:13 PM 43 4,204.00 LSE
16 Oct 2026, 04:14 PM 80 4,203.00 LSE
16 Oct 2026, 04:14 PM 121 4,202.00 LSE
16 Oct 2026, 04:14 PM 107 4,199.00 LSE
16 Oct 2026, 04:14 PM 22 4,199.00 LSE
16 Oct 2026, 04:14 PM 29 4,199.00 LSE
16 Oct 2026, 04:14 PM 93 4,199.00 LSE
16 Oct 2026, 04:14 PM 1 4,199.00 LSE
16 Oct 2026, 04:15 PM 84 4,196.00 LSE
16 Oct 2026, 04:15 PM 108 4,198.00 LSE
16 Oct 2026, 04:15 PM 19 4,196.00 LSE
16 Oct 2026, 04:16 PM 80 4,200.00 LSE
16 Oct 2026, 04:17 PM 123 4,197.00 LSE
16 Oct 2026, 04:17 PM 115 4,197.00 LSE
16 Oct 2026, 04:17 PM 7 4,197.00 LSE
16 Oct 2026, 04:17 PM 107 4,196.00 LSE
16 Oct 2026, 04:17 PM 440 4,203.00 LSE
16 Oct 2026, 04:17 PM 104 4,203.00 LSE
16 Oct 2026, 04:17 PM 67 4,203.00 LSE
16 Oct 2026, 04:17 PM 80 4,203.00 LSE
16 Oct 2026, 04:17 PM 35 4,203.00 LSE
16 Oct 2026, 04:17 PM 80 4,203.00 LSE
16 Oct 2026, 04:17 PM 126 4,203.00 LSE
16 Oct 2026, 04:17 PM 80 4,206.00 LSE
16 Oct 2026, 04:17 PM 113 4,206.00 LSE
16 Oct 2026, 04:18 PM 48 4,208.00 LSE
16 Oct 2026, 04:18 PM 129 4,210.00 LSE
16 Oct 2026, 04:18 PM 112 4,210.00 LSE
16 Oct 2026, 04:18 PM 20 4,210.00 LSE
16 Oct 2026, 04:18 PM 80 4,210.00 LSE
16 Oct 2026, 04:18 PM 80 4,207.00 LSE
16 Oct 2026, 04:18 PM 21 4,207.00 LSE
16 Oct 2026, 04:19 PM 109 4,207.00 LSE
16 Oct 2026, 04:19 PM 2 4,206.00 LSE
16 Oct 2026, 04:20 PM 126 4,205.00 LSE
16 Oct 2026, 04:20 PM 59 4,204.00 LSE
16 Oct 2026, 04:20 PM 56 4,204.00 LSE
16 Oct 2026, 04:20 PM 44 4,208.00 LSE
16 Oct 2026, 04:20 PM 80 4,208.00 LSE
16 Oct 2026, 04:21 PM 119 4,204.00 LSE
16 Oct 2026, 04:22 PM 1 4,199.00 LSE
16 Oct 2026, 04:22 PM 115 4,199.00 LSE
16 Oct 2026, 04:22 PM 132 4,196.00 LSE
16 Oct 2026, 04:22 PM 59 4,195.00 LSE
16 Oct 2026, 04:23 PM 88 4,196.00 LSE
16 Oct 2026, 04:23 PM 114 4,195.00 LSE
16 Oct 2026, 04:24 PM 88 4,191.00 LSE
16 Oct 2026, 04:24 PM 66 4,191.00 LSE
16 Oct 2026, 04:24 PM 132 4,191.00 LSE
16 Oct 2026, 04:24 PM 38 4,189.00 LSE
16 Oct 2026, 04:24 PM 79 4,189.00 LSE
16 Oct 2026, 04:24 PM 88 4,189.00 LSE
16 Oct 2026, 04:25 PM 110 4,196.00 LSE
16 Oct 2026, 04:25 PM 1 4,197.00 LSE
16 Oct 2026, 04:25 PM 123 4,200.00 LSE
16 Oct 2026, 04:25 PM 2 4,200.00 LSE
16 Oct 2026, 04:25 PM 119 4,199.00 LSE
16 Oct 2026, 04:25 PM 114 4,199.00 LSE
16 Oct 2026, 04:25 PM 126 4,198.00 LSE
16 Oct 2026, 04:25 PM 23 4,198.00 LSE
16 Oct 2026, 04:25 PM 35 4,197.00 LSE
16 Oct 2026, 04:25 PM 88 4,197.00 LSE
16 Oct 2026, 04:25 PM 117 4,195.00 LSE
16 Oct 2026, 04:25 PM 88 4,194.00 LSE
16 Oct 2026, 04:25 PM 128 4,188.00 LSE
16 Oct 2026, 04:25 PM 118 4,187.00 LSE
16 Oct 2026, 04:25 PM 129 4,187.00 LSE
16 Oct 2026, 04:25 PM 37 4,188.00 LSE
16 Oct 2026, 04:25 PM 35 4,189.00 LSE
16 Oct 2026, 04:25 PM 83 4,189.00 LSE
16 Oct 2026, 04:25 PM 18 4,189.00 LSE
16 Oct 2026, 04:26 PM 86 4,190.00 LSE
16 Oct 2026, 04:26 PM 66 4,190.00 LSE
16 Oct 2026, 04:26 PM 35 4,188.00 LSE
16 Oct 2026, 04:26 PM 83 4,188.00 LSE
16 Oct 2026, 04:26 PM 12 4,188.00 LSE
16 Oct 2026, 04:26 PM 75 4,188.00 LSE
16 Oct 2026, 04:27 PM 25 4,193.00 LSE
16 Oct 2026, 04:27 PM 88 4,193.00 LSE
16 Oct 2026, 04:27 PM 44 4,193.00 LSE
16 Oct 2026, 04:27 PM 88 4,193.00 LSE
16 Oct 2026, 04:27 PM 24 4,194.00 LSE
16 Oct 2026, 04:27 PM 88 4,194.00 LSE
16 Oct 2026, 04:28 PM 129 4,194.00 LSE
16 Oct 2026, 04:28 PM 87 4,192.00 LSE
16 Oct 2026, 04:28 PM 29 4,192.00 LSE
16 Oct 2026, 04:28 PM 55 4,192.00 LSE
16 Oct 2026, 04:29 PM 29 4,194.00 LSE
16 Oct 2026, 04:29 PM 32 4,194.00 LSE
16 Oct 2026, 04:29 PM 88 4,194.00 LSE
16 Oct 2026, 04:29 PM 29 4,194.00 LSE
16 Oct 2026, 04:29 PM 33 4,193.00 LSE
16 Oct 2026, 04:29 PM 115 4,193.00 LSE
16 Oct 2026, 04:29 PM 34 4,189.00 LSE

CONTACT INFORMATION

For Investor Relations Enquiries: For Media Enquiries:
Jack Garman Brunswick Group LLP in London
Vice President of Investor Relations Carole Cable, Partner
+44 203 011 2723 + 44 207 404 5959
investor@endeavourmining.com ccable@brunswickgroup.com

ABOUT ENDEAVOUR MINING PLC

Endeavour Mining is one of the world’s senior gold producers and the largest in West Africa, with operating assets across Senegal, Cote d’Ivoire and Burkina Faso and a strong portfolio of advanced development projects and exploration assets.

A member of the World Gold Council, Endeavour is committed to the principles of responsible mining and delivering sustainable value to its employees, stakeholders and the communities where it operates. Endeavour is admitted to listing and to trading on the London Stock Exchange and the Toronto Stock Exchange, under the symbol EDV.

For more information, please visit www.endeavourmining.com.

CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATION

This news release contains “forward-looking statements” within the meaning of applicable securities laws.  All statements, other than statements of historical fact, are “forward-looking statements”. Generally, these forward-looking statements can be identified by the use of forward-looking terminology such as “expects”, “expected”, “budgeted”, “forecasts”, and “anticipates”.

Forward-looking statements, while based on management’s best estimates and assumptions, are subject to risks and uncertainties that may cause actual results to be materially different from those expressed or implied by such forward-looking statements, including but not limited to: risks related to the successful integration of acquisitions; risks related to international operations; risks related to general economic conditions and credit availability, actual results of current exploration activities, unanticipated reclamation expenses; changes in project parameters as plans continue to be refined; fluctuations in prices of metals including gold; fluctuations in foreign currency exchange rates, increases in market prices of mining consumables, possible variations in ore reserves, grade or recovery rates; failure of plant, equipment or processes to operate as anticipated; accidents, labour disputes, title disputes, claims and limitations on insurance coverage and other risks of the mining industry; delays in the completion of development or construction activities, changes in national and local government regulation of mining operations, tax rules and regulations, and political and economic developments in countries in which Endeavour operates. Although Endeavour has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. Please refer to Endeavour’s most recent Annual Information Form filed under its profile at www.sedarplus.ca for further information respecting the risks affecting Endeavour and its business.

Attachment

Please see below information about transactions made under the buy-back programme for Equinor ASA (OSE:EQNR, NYSE:EQNR) for shares to be used in the share-based incentive programmes for employees and management.

Date on which the buy-back programme was announced: 4 February 2026.

The duration of the buy-back programme: 13 February 2026 to 15 January 2027.

Size of the buy-back programme: The total purchase amount under the programme is NOK 1,971,000,000 and the maximum shares to be acquired is 19,600,000 shares, of which up to 7,920,000 shares can be acquired in the period from 13 February 2026 to 15 May 2026, and up to 11,680,000 shares can be acquired in the period from 15 May 2026 to 15 January 2027.

On 15 October 2026, Equinor ASA has purchased a total of 389,058 own shares at the Oslo Stock Exchange at an average price of NOK 429.2415 per share.

Aggregated overview of transactions per day:

Date Aggregated volume (number of shares) Weighted average share price (NOK)  Total transaction value (NOK) 
15 October 2026 389,058 429.2415 166,999,840
Previously disclosed buy-backs under the programme (accumulated) 3,778,442 344.8107 1,302,847,119
Total buy-backs under the programme 4,167,500 352.6927 1,469,846,959

Following the completion of the above transactions, Equinor ASA owns a total of 23,077,317 own shares, corresponding to 0.97% of Equinor ASA’s share capital, including shares purchased under the previous buy-back programme for the share-based incentive programmes for employees, and shares purchased under Equinor’s disclosed buy-back programmes which will be used to reduce the issued share capital of the company.

This is information that Equinor ASA is obliged to make public pursuant to the EU Market Abuse Regulation and subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act.

Appendix: A detailed overview of all transactions made under the buy-back programme that have been carried out during the above-mentioned time period is attached to this report and available at www.newsweb.no.

Further information from

Investor relations
Bård Glad Pedersen, senior vice president Investor Relations,
+47 918 01 791

Media
Sissel Rinde, vice president Media Relations,
+47 412 60 584

Attachment

Press release – Neuilly-sur-Seine, Tuesday, October 19, 2026 – 8.00 am

Availability of the Merger Auditor’s Report

ARGAN hereby informs its shareholders that the report prepared by Mr. Olivier Péronnet, Partner at Finexsi – Expert & Conseil Financier, acting as merger auditor appointed by order of the President of the Nanterre Commercial Activities Court dated July 28, 2026, is available to them as of today.

In his report, prepared in connection with the proposed cross-border merger with Warehouses De Pauw NV (“WDP”), a company incorporated under Belgian law, the merger auditor concludes as follows:

  • “The exchange ratio of 3 WDP shares for 1 ARGAN share, following the exceptional distribution of €11 per share, as agreed by the parties, is fair; and
  • The withdrawal price of €71.10 agreed upon by the parties, corresponding to €60.10 following the exceptional distribution of €11.00 per share, is based on valuation criteria that we consider appropriate and appears justified in the context of the merger.”

The report is available for consultation in its entirety on the argan.fr website, under the “General Meetings – 2026” section of the “Investors & Shareholders” tab.

This report supplements the documentation prepared in advance of ARGAN’s Combined General Meeting of Shareholders, which will be held on Friday, November 20, 2026, at 11:00 a.m. at the Palais Brongniart (16, place de la Bourse, 75002 Paris), and at which shareholders will be asked, in particular, to vote on the proposed merger.

The proposed merger is progressing in line with the planned timetable, with completion expected in the first quarter of 2027, subject to the satisfaction of the conditions precedent to the transaction, including approval by the shareholders of both companies. Further information on the proposed merger is available on the website www.wdp-argan.eu.

2026 financial calendar

  • November 20: Combined General Meeting (WDP merger project)

20271 financial calendar (Publication of the press release after closing of the stock exchange)

  • January 4: Net sales of 4th quarter 2026
  • January 21: Annual results 2026
  • March 25: General Meeting 2027

Disclaimer

The envisaged merger does not constitute an offering in Belgium, France or another state or jurisdiction, other than the United States, where the offering will be made pursuant to the exemption of Rule 802 under the U.S. Securities Act of 1933, as amended (the “Securities Act”). No action has been or will be taken to permit an offering in any state or jurisdiction other than the United States.

This press release may not be construed as a prospectus or an information document as referred to in Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 June 2017 on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market (the “Prospectus Regulation”), or any implementing measure in any relevant member state of the European Economic Area.

This press release does not constitute an offer or solicitation to acquire, purchase, subscribe for, sell or exchange any securities in Australia, Hong Kong, Canada, Japan, New Zealand, South Africa, Switzerland and the United Kingdom, or any other state or jurisdiction where to do so would constitute a violation of the laws of that state or jurisdiction, and no such offer (or solicitation) may be made in any such jurisdiction. Any failure to comply with this restriction may constitute a violation of the securities laws of Australia, Hong Kong, Canada, Japan, New Zealand, South Africa, Switzerland and the United Kingdom, or other applicable laws. All people who read this announcement should inform themselves of any such restrictions and comply with them. This announcement is not intended for release, publication, or distribution, in whole or in part, in or into, directly or indirectly, any jurisdiction in which such release, publication, or distribution could constitute a breach of the applicable laws of such jurisdiction. ARGAN and WDP explicitly decline any liability for breach of these restrictions by any person.

The shares to be issued in connection with the envisaged merger may not be offered or sold in the United States except pursuant to an effective registration statement under the Securities Act, or pursuant to a valid exemption from registration. WDP is offering its shares in connection with the envisaged merger in the United States in reliance on the exemption from registration provided by Rule 802 under the Securities Act (“Rule 802”).

Important Notice to U.S. Investors

The merger will involve the exchange of securities of a public limited liability company incorporated in Belgium and a public limited company incorporated in France. The offer of shares in the merger is subject to disclosure requirements of a foreign country that are different from those of the United States. Financial statements included or referred to in this document, if any, have been prepared in accordance with foreign accounting standards that may not be comparable to the financial statements of United States companies. It may be difficult for you to enforce your rights and any claim you may have arising under the U.S. federal securities laws, since WDP is located in a foreign country, and some or all of its officers and directors may be residents of a foreign country. You may not be able to sue a foreign company or its officers or directors in a foreign court for violations of the U.S. securities laws. It may be difficult to compel a foreign company and its affiliates to subject themselves to a U.S. court’s judgment.

You should be aware that WDP may purchase securities otherwise than in the context of the merger, such as in open market or privately negotiated purchases.

About ARGAN

ARGAN is the only French real estate company specializing in the DEVELOPMENT & RENTAL OF PREMIUM WAREHOUSES listed on EURONEXT and is the leading player in its market in France. Building on a unique customer-centric approach, ARGAN develops PREMIUM and pre-let Au0nom® -labelled warehouses – i.e., which produce their own energy for self-consumption – for blue-chip companies, with tailor-made services throughout all project phases from the development milestones to the rental management. As at June 30, 2026, ARGAN represented a portfolio of 3.9 million sq.m, with close to 110 warehouses located in the continental area of France. Appraised at a total of €4.3 billion (excl. duties), this portfolio generates a yearly rental income of €224 million (yearly rental income based on the portfolio delivered as at June 30, 2026).
Profitability, well-mastered debt and sustainability are at the heart of ARGAN’s DNA. The financial solidity of the Group’s model is notably reflected in its Investment-grade rating (BBB- with a stable outlook) with Standard & Poor’s. ARGAN is also deploying a committed ESG policy addressing all its stakeholders. Achievements as part of this roadmap are regularly recognized by third-party agencies such as GRESB (rated: 83/100), Sustainalytics (low extra-financial risk), Ethifinance (gold medal) and Ecovadis (silver medal – top 15% amongst rated companies).
ARGAN is a listed real estate investment company (French SIIC), on Compartment A of Euronext Paris (ISIN FR0010481960 – ARG) and is included in the Euronext SBF 120, CAC All-Share, EPRA Europe and IEIF SIIC France indices.

www.argan.fr

Francis Albertinelli – CFO
Aymar de Germay – General Secretary
Samy Bensaid – Head of Investor Relations
Phone: +33 1 47 47 47 40
E-mail: contact@argan.fr

Marlène Brisset – Media relations
Phone: +33 6 59 42 29 35
E-mail: argan@cdrconsultancy.com

   


1 Indicative timetable, subject to change, in particular depending on the completion of the merger.

Attachment

Kenmare Resources plc
(“Kenmare” or the “Company” or the “Group”)

20 October 2026

Response to Mozambican media reports regarding Implementation Agreement

Kenmare Resources plc (LSE:KMR, ISE:KMR), one of the leading global producers of titanium minerals and zircon, which operates the Moma Titanium Minerals Mine (the “Mine” or “Moma”) in northern Mozambique, notes the recent reports in the Mozambican media regarding the finalisation of Moma’s Implementation Agreement (“IA”), following comments from a spokesman of the Government of Mozambique (the “Government”). The Company has not, to date, received any official confirmation or other correspondence on this matter from the Government. The Company is therefore unable to confirm the status or the terms of any renewal until it receives such confirmation or communication.

Kenmare remains committed to achieving a positive near-term conclusion of the IA renewal process and the Company will update the market of any developments as soon as possible.

Background on Implementation Agreement

The IA grants certain rights and concessions to Kenmare Moma Processing (Mauritius) Limited in connection with its processing and export activities. It also contains unambiguous renewal rights in relation to those rights and concessions on the same terms. Mining operations at Moma are conducted under a separate regulatory framework that is not impacted by the IA process.

Kenmare has been engaging with the Government on potential amendments to the applicable terms. Although the original expiry date was 21 December 2024, the Government provided confirmation that Kenmare’s existing rights and benefits remain in full force and effect pending conclusion of the extension process.

For further information, please contact:

Kenmare Resources plc
Katharine Sutton / David Weeks
Investor Relations
ir@kenmareresources.com
Tel: +353 1 671 0411
Mob: +353 87 663 0875 / +353 87 708 2525

Murray (PR advisor)
Paul O’Kane
pokane@murraygroup.ie
Tel: +353 1 498 0300
Mob: +353 86 609 0221

About Kenmare Resources

Kenmare Resources plc is one of the world’s largest producers of titanium minerals. Listed on the London Stock Exchange and the Euronext Dublin, Kenmare operates the Moma Titanium Minerals Mine in Mozambique. Moma’s production accounts for approximately 6% of global titanium feedstocks and the Company supplies to customers operating in more than 15 countries. Kenmare produces raw materials that are ultimately consumed in everyday quality-of-life items such as paints, plastics and ceramic tiles.

OSB GROUP PLC
ISIN: GB00BLDRH360
20 October 2026

LEI number: 213800ZBKL9BHSL2K459

OSB GROUP PLC (the “Company”)
Share Buyback Programme – Transactions in Own Shares and completion of buyback

The Company announces that on 19 October 2026 it had purchased a total of 75,220 of its ordinary shares of £0.01 each (the “ordinary shares“) on the London Stock Exchange, CBOE BXE ,CBOE CXE and Aquis Exchange, through the Company’s broker Jefferies International Limited as detailed below. The repurchased ordinary shares will be cancelled.

19 October 2026 London Stock Exchange CBOE BXE CBOE CXE Aquis Exchange
Number of ordinary shares purchased 75,220 0 0 0
Highest price paid (per ordinary share) 492.20p 0.00p 0.00p 0.00p
Lowest price paid (per ordinary share) 485.00p 0.00p 0.00p 0.00p
Volume weighted average price paid (per ordinary share) 489.50p 0.00p 0.00p 0.00p

The purchases form part of the Company’s share buyback programme announced on 5 March 2026.

Following settlement of the above purchases and cancellation of the purchased ordinary shares, the Company’s total number of ordinary shares in issue shall be 335,357,246 ordinary shares.

No ordinary shares are held in treasury. Therefore, the total number of voting rights in the Company is 335,357,246 and may be used by shareholders (and others with notification obligations) as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change in their interest in, the Company under the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules.

In accordance with Article 5(2)(b) of Regulation (EU) No 596/2024 as incorporated into and implemented under English law (including by virtue of the European Union (Withdrawal) Act 2028), the detailed breakdown of individual trades made by Jefferies International Limited on behalf of the Company as part of the share buyback programme is set out below.

The Company announces that, following the purchase of these shares, the share buy-back programme announced on 5 March 2026 has completed. Since the commencement of the buy-back, the Company has repurchased for cancellation 19,410,811 ordinary shares in aggregate at a volume weighted average price of 515.18p per ordinary share for a total consideration of approximately £100 million.

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

Schedule of Purchases

Issuer Name OSB GROUP PLC
LEI 213800ZBKL9BHSL2K459
ISIN GB00BLDRH360
Intermediary Name Jefferies International Limited
Intermediary Code JEFFGB2XXXX
Timezone GMT
Currency GBP

Individual Transactions:

Please see attached PDF for full list of transactions.

Attachment

Presentation highlights new translational data evaluating plasma NfL and GFAP as biomarkers of neuroaxonal injury and neuroinflammation

ZUG, Switzerland, October 20, 2026 — Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on breakthrough innovations to address significant unmet medical needs in neuro-ophthalmology, today announced that new biomarker data from the Phase 2 ACUITY trial of Privosegtor will be featured in a late-breaking session at the 10th Joint ACTRIMS-ECTRIMS Meeting (MSToronto 2026), on October 21-23, 2026, in Toronto, Canada.

The presentation will unveil new analyses evaluating circulating neuroaxonal and neuroinflammatory biomarkers, specifically plasma neurofilament light chain (NfL) and glial fibrillary acidic protein (GFAP), in patients with acute optic neuritis (ON). These translational endpoints provide critical insight into acute central nervous system injury cascades and the biological rationale underlying neuroprotection.

The presentation will provide congress attendees, clinical investigators, members of the neuro-ophthalmology and multiple sclerosis communities with an opportunity to hear directly from Professor Céline Louapre, the principal investigator of the ACUITY Phase 2 trial, and discuss the new findings during the session.

Details of Oculis’ presentation at the ACTRIMS-ECTRIMS joint meeting are as follows:

      Presentation: Effect of Privosegtor on Plasma Neurofilament-Light and Glial Fibrillary Acidic Protein Levels in the Phase 2 ACUITY Trial in Optic Neuritis
      Presenter: Céline Louapre, M.D., Ph.D., Pitié-Salpêtrière Hospital
      Session: Late Breaking Abstracts
      Presentation ID: P1507
      Date/Time: Thursday, October 22, 2026; 4:30 – 6:30 p.m. EDT
      Location: Metro Toronto Convention Centre

“Optic neuritis and demyelinating relapses represent a high-stakes clinical race against permanent neuro-axonal loss and irreversible functional deficits such as visual impairments,” said Riad Sherif, M.D., Chief Executive Officer of Oculis. “With no approved neuroprotective therapies currently available to protect retinal ganglion cells and their axons, which transmit visual signals from the eye to the brain, deep translational analyses are vital to advancing care. At ECTRIMS, Professor Céline Louapre will present objective plasma biomarker readouts from the Phase 2 ACUITY trial, offering key insights into the biological pathways of optic neuritis and the neuroprotective potential of Privosegtor. We invite the international clinical and scientific community to join us for this late-breaking presentation as we work to advance the next frontier of neuroprotection.”

Following the successful Phase 2 ACUITY trial, Privosegtor was granted Breakthrough Therapy designation from the FDA and Priority Medicines (PRIME) designation from the EMA. Oculis’ PIONEER (Privosegtor Investigation in Optic Neuropathies Efficacy Evaluation Research) program includes two registrational trials evaluating Privosegtor in patients with optic neuritis. The first trial, PIONEER-1, is currently enrolling patients with acute-onset ON across a broad population, including individuals with and without multiple sclerosis. Oculis plans to file an IND for Privosegtor in acute MS relapses. The Company will host an R&D Day on December 8, 2026, to provide updates on its differentiated late-stage pipeline, including Privosegtor and Licaminlimab.

– Ends –

About Privosegtor
Privosegtor, a novel peptoid small-molecule candidate that crosses the blood-brain and retinal barriers, has the potential to become the first neuroprotective therapy for optic neuritis (ON) and other neuro-ophthalmic and neuro-axonal diseases. Positive results from the ACUITY Phase 2 trial showed Privosegtor’s neuroprotective potential, as evidenced by improved visual function, corroborated by anatomical preservation of the retina, including the GCIPL and RNFL layers, and reduced neurofilament levels in the blood after an acute episode of optic neuritis. Consistent results were observed in animal models of glaucoma, optic neuritis, and multiple sclerosis (MS), where Privosegtor preserved retinal ganglion cells and was associated with improvements in mobility (clinical function disability) in the MS model.

Privosegtor has received Breakthrough Therapy designation from the U.S. Food and Drug Administration (FDA) and Priority Medicines (PRIME) designation from the European Medicines Agency (EMA) as well as Orphan Drug designation from both the FDA and the EMA for ON. Privosegtor is currently being evaluated in Oculis’ PIONEER (Privosegtor Investigation in Optic Neuropathies Efficacy Evaluation Research) program, which includes two registrational trials in ON and one registrational trial in non-arteritic anterior ischemic optic neuropathy (NAION). Building on the ACUITY Phase 2 dataset in ON and constructive FDA pre-IND feedback, Oculis is also planning an IND submission for Privosegtor for the treatment of acute MS relapses.

Privosegtor is an investigational drug and has not received regulatory approval for commercial use in any country.

About Optic Neuritis

Optic Neuritis (ON) is a rare condition characterized by an acute inflammation of the optic nerve that can lead to permanent visual impairment. It affects up to 8 in 100,000 people worldwide with a U.S. annual incidence estimated to be >30,000 and often represents the first sign of multiple sclerosis1,2. It mainly occurs in adults between the age of 20 and 40 years and is more frequent in women (2:1)3. ON is a type of neuropathy (nerve disease) that happens when acute inflammation of the optic nerve affects the signals traveling from the eyes through the brain, causing pain, vision loss and other symptoms. The cells that make up the optic nerve have a lipid protective coating called a myelin sheath, which is preferentially damaged in ON. Without myelin, the optic nerve cells can’t send signals properly and axons can be irreversibly lost. To date there is no specific therapy approved for acute optic neuritis and the unmet needs remain for therapies that can prevent vision loss after an acute episode by reducing nerve cell permanent damage or death.

About Oculis

Oculis is a global biopharmaceutical company (Nasdaq: OCS; XICE: OCS) focused on breakthrough innovations to address significant unmet medical needs in neuro-ophthalmology. Oculis’ highly differentiated late-stage clinical pipeline focuses on two core product candidates. Privosegtor is a breakthrough neuroprotective candidate in the PIONEER program, which consists of studies intended to support registration plans for treatment of optic neuropathies, including optic neuritis (ON) and non-arteritic anterior ischemic optic neuropathy (NAION). Privosegtor also has potential to be developed for additional indications in other neuro-ophthalmic and neuro-axonal diseases. Licaminlimab is a novel, topical anti-TNFα in a registrational trial, and is being developed with a genotype-based approach for treating patients with dry eye disease (DED). Headquartered in Switzerland with operations in the U.S., Iceland and Switzerland, Oculis is led by an experienced management team with a successful track record and supported by leading international healthcare investors.
        
For more information, please visit: www.oculis.com

Oculis Contact
Ms. Sylvia Cheung, CFO
sylvia.cheung@oculis.com
mailto:

Investor Relations
LifeSci Advisors
Corey Davis, Ph.D.
cdavis@lifesciadvisors.com

Media Relations
ICR Healthcare
Amber Fennell
oculis@icrhealthcare.com

Cautionary Statement Regarding Forward Looking Statements

This press release contains forward-looking statements and information. For example, statements regarding the potential benefits of the Company’s product candidates, including the potential for Privosegtor to become the first neuroprotection therapy for optic neuritis and its potential broad applicability across neurology, including in acute MS relapses, the initiation, enrollment, timing, progress and results of current and future clinical trials, Oculis’ research and development programs, regulatory and business strategy; Oculis’ future development plans; the timing or likelihood of regulatory filings and approvals; and statements about market opportunity, are forward-looking. All forward-looking statements are based on estimates and assumptions that, while considered reasonable by Oculis and its management, are inherently uncertain and are inherently subject to risks, variability, and contingencies, many of which are beyond Oculis’ control. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on by an investor as, a guarantee, assurance, prediction or definitive statement of a fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Results of earlier stage clinical trials may not be replicated in subsequent clinical trials. All forward-looking statements are subject to risks, uncertainties and other factors that may cause actual results to differ materially from those that we expected and/or those expressed or implied by such forward-looking statements. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of Oculis, including those set forth in the Risk Factors section of Oculis’ annual report on Form 20-F and any other documents filed with the U.S. Securities and Exchange Commission (SEC). Copies of these documents are available on the SEC’s website, www.sec.gov. Oculis undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

References:

  1. Martínez-Lapiscina EH, et al. (2014): Is the incidence of optic neuritis rising? Evidence from an epidemiological study in Barcelona (Spain) 2008-2012. J Neurol. 2014 Apr; 261(4): 759-767.
  2. Pérez-Cambrodí RJ, Gómez-Hurtado Cubillana A, Merino-Suárez ML, Piñero-Llorens DP, Laria-Ochaita C. Optic neuritis in pediatric population: a review in current tendencies of diagnosis and management. J Optom. 2014 Jul-Sep;7(3):125-30.
  3. Sing Hayreh S. (2008): Nonarteritic anterior ischemic optic neuropathy: natural history of visual outcome. Ophthalmology. 2088 Feb;115(2):298-305.

Please see below information about transactions made under the third tranche of the 2026 share buy-back programme for Equinor ASA (OSE:EQNR, NYSE:EQNR, CEUX:EQNRO, TQEX:EQNRO).

Date on which the buy-back tranche was announced: 22 July 2026.

The duration of the buy-back tranche: 23 July to no later than 26 October 2026.

Further information on the tranche can be found in the stock market announcement on its commencement dated 22 July 2026, available here: https://newsweb.oslobors.no/message/678529

From 12 October to 16 October 2026, Equinor ASA has purchased a total of 540,275 own shares at an average price of NOK 425.4849 per share.

Overview of transactions:

Date Trading venue Aggregated daily volume (number of shares) Daily weighted average share price (NOK) Total daily transaction value (NOK)
         
12 October OSE 137,775 418.3224 57,634,368.66
  CEUX      
  TQEX      
         
13 October OSE 137,500 420.9934 57,886,592.50
  CEUX      
  TQEX      
         
14 October OSE 132,000 431.5169 56,960,230.80
  CEUX      
  TQEX      
         
15 October OSE      
  CEUX      
  TQEX      
         
16 October OSE 133,000 431.5615 57,397,679.50
  CEUX      
  TQEX      
         
Total for the period OSE 540,275 425.4849 229,878,871.46
  CEUX      
  TQEX      
         
Previously disclosed buy-backs under the tranche

OSE 7,697,832 396.5241 3,052,375,860.73
CEUX      
TQEX      
Total 7,697,832 396.5241 3,052,375,860.73
         
Total buy-backs under the tranche (accumulated)

OSE 8,238,107 398.4234 3,282,254,732.19
CEUX      
TQEX      
Total 8,238,107 398.4234 3,282,254,732.19

Following completion of the above transactions, Equinor ASA owns a total of 23,077,317 own shares, corresponding to 0.97% of Equinor ASA’s share capital, including shares under Equinor’s share savings programme (excluding shares under Equinor’s share savings programme, Equinor owns a total of 11,773,082 own shares, corresponding to 0.49% of the share capital).

This is information that Equinor ASA is obliged to make public pursuant to the EU Market Abuse Regulation and that is subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act.

Appendix: An overview of all transactions made under the buy-back tranche that have been carried out during the above-mentioned time period is attached to this report and available at www.newsweb.no.

Contact details:

Investor relations
Bård Glad Pedersen, senior vice president Investor Relations,
+47 918 01 791

Media
Sissel Rinde, vice president Media Relations,
+47 412 60 584

Attachment

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.